<DOC>
	<DOC>NCT01145885</DOC>
	<brief_summary>Investigation of absorption, distribution, metabolism and excretion (ADME) and assessment of safety, tolerability and preliminary therapeutic effects of [14C]volasertib in patients with advanced solid tumours.</brief_summary>
	<brief_title>BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: Inclusion Criteria 1. Patients with histologically or cytologically confirmed diagnosis of advanced, non resectable and / or metastatic solid tumour Inclusion Criteria 2. Male Inclusion Criteria 3. Age &gt;=18 and =&lt;70 years Inclusion Criteria 4. Written informed consent Inclusion Criteria 5. Eastern Cooperative Oncology Group (ECOG) performance score =&lt;2 Inclusion Criteria 6. Recovery from Common Terminology Criteria for Adverse Events (CTCAE) Grade &gt;=2 therapyrelated toxicities from previous chemo, hormone, immuno, or radiotherapy Exclusion criteria: Exclusion Criteria 1. Serious concomitant nononcological disease considered by the investigator Exclusion Criteria 2. Active infectious disease Exclusion Criteria 3. Viral hepatitis, Human Immunodeficiency Virus (HIV) infection Exclusion Criteria 4. Clinical evidence of active brain metastasis during the past 6 months Exclusion Criteria 5. Second malignancy currently requiring active therapy Exclusion Criteria 6. Absolute neutrophil count less than 1,500/mm3 Exclusion Criteria 7. Platelet count less than 100,000/mm3 Exclusion Criteria 8. Total bilirubin greater than 1.5 mg/dL Exclusion Criteria 9. Aspartate amino transferase (AST) and / or alanine amino transferase (ALT) greater than 2.5 times the upper limit of normal (if related to liver metastases greater than five times the upper limit of normal) Exclusion Criteria 10. Serum creatinine greater than 1.5x Upper Limit of Normal (ULN). Exclusion Criteria 11. Known history of QT/QTcFprolongation Exclusion Criteria 12. Patients who are sexually active and having a partner with childbearing potential and unwilling to use a medically acceptable method of contraception Exclusion Criteria 13. Treatment with other investigational drugs or participation in another clinical trial Exclusion Criteria 14. Chemo, radio immuno, or moleculartargeted cancertherapy within the past four weeks prior to start of therapy or concomitantly with this trial. This restriction does not apply to steroids and bisphosphonates. Exclusion Criteria 15. Alcohol abuse Exclusion Criteria 16. Life expectancy less than 12 weeks Exclusion Criteria 17. Potent Cytochrome P450 enzyme (CYP) 3A4 and Pglycoprotein inhibitors or inducers Exclusion Criteria 18. History of allergy/hypersensitivity</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>